Healthcare - Biotechnology - NASDAQ - US
$ 0.0001
0 %
$ 3.07 K
Market Cap
0.0
P/E
BALANCE SHEET
3.73 M
ASSETS
9.97 M
LIABILITIES
-6.25 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Comera Life Sciences Holdings, Inc.
| Current Assets | 3.06 M |
| Cash & Short-Term Investments | 447 K |
| Receivables | 34.3 K |
| Other Current Assets | 2.58 M |
| Non-Current Assets | 664 K |
| Long-Term Investments | 50 K |
| PP&E | 571 K |
| Other Non-Current Assets | 43.2 K |
| Current Liabilities | 5.06 M |
| Accounts Payable | 1.46 M |
| Short-Term Debt | 655 K |
| Other Current Liabilities | 2.95 M |
| Non-Current Liabilities | 4.92 M |
| Long-Term Debt | 120 K |
| Other Non-Current Liabilities | 4.8 M |
Balance Sheet
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|
| ASSETS | |||
| Cash & Cash Equivalents | 0.4 | 6.5 | 0.2 |
| Short Term Investments | 0 | 0 | 0 |
| Receivables | 34.3 K | 0.2 | 0.1 |
| Inventory | 0 | 2 K | 21.9 K |
| Other Current Assets | 2.6 | 47.4 K | 39.7 K |
| Total Current Assets | 3.1 | 6.8 | 0.3 |
| PP&E | 0.6 | 0.6 | 0.2 |
| Intangible Assets | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 |
| Long Term Investments | 50 K | 50 K | 107.1 |
| Other Long Term Assets | 43.2 K | 32.2 K | (107.0) |
| Other Assets | 0 | 0 | 0 |
| Total Assets | 3.7 | 7.4 | 0.5 |
| LIABILITIES | |||
| Accounts Payable | 1.5 | 0.4 | 97.6 K |
| Short Term Debt | 0.7 | 0.1 | 0 |
| Other Current Liabilities | 2.8 | 0.5 | 0.1 |
| Total Current Liabilities | 5.1 | 1.0 | 0.2 |
| Long Term Debt | 0.1 | 0.2 | 0.2 |
| Deferred Tax Income | 0 | 0 | 0 |
| Other Liabilities | 4.8 | 20.9 | 0 |
| Total Liabilities | 10.0 | 22.1 | 0.4 |
| EQUITY | |||
| Common Stock | 1.67 K | 31 | 10.7 |
| Retained Earnings | (34.9) | (16.9) | (11.4) |
| Other Accumulative Comprehensive Income/Loss | 0 | (20.9) | 0 |
| Total Equity | (6.2) | (14.7) | 0.2 |
| Total Liabilities and Equity | 3.7 | 7.4 | 0.5 |
| SHARES OUTSTANDING | |||
| Common Shares Outstanding | 10.5 | 19.1 | 19.1 |